Jeffrey S Farrow
Chief Financial Officer and Chief Strategy Officer; Director · 6 filings · Latest: Jul 27, 2026
ACHIEVE LIFE SCIENCES, INC.
Tarsus Pharmaceuticals, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
TARS | Jeffrey S Farrow | Chief Financial Officer and Chief Strategy Officer | Jun 16, 2026 | Sale | $60.95 | 14,396 | $877.4K | 56,801 | |
TARS | Jeffrey S Farrow | Chief Financial Officer and Chief Strategy Officer | Jun 15, 2026 | Option Exercise | — | 27,881 | — | 71,197 | |
TARS | Farrow Jeffrey S | — | Jun 16, 2026 | Proposed Sale | $60.95 | 14,396 | $877.5K | — | |
TARS | Jeffrey S Farrow | Chief Financial Officer and Chief Strategy Officer | Mar 19, 2026 | Sale | $67.00 | 2,186 | $146.5K | 43,316 | |
TARS | Jeffrey S Farrow | Chief Financial Officer and Chief Strategy Officer | Mar 18, 2026 | Sale | $68.71 | 2,133 | $146.6K | 45,502 | |
TARS | Jeffrey S Farrow | Chief Financial Officer and Chief Strategy Officer | Mar 17, 2026 | Sale | $69.42 | 2,111 | $146.5K | 47,635 | |
TARS | Farrow Jeffrey S | — | Mar 19, 2026 | Proposed Sale | $67.00 | 2,186 | $146.5K | — | |
TARS | Farrow Jeffrey S | — | Mar 18, 2026 | Proposed Sale | $68.71 | 2,133 | $146.6K | — | |
TARS | Jeffrey S Farrow | Chief Financial Officer and Chief Strategy Officer | Mar 15, 2026 | Option Exercise | — | 13,042 | — | 49,746 | |
TARS | Farrow Jeffrey S | — | Mar 17, 2026 | Proposed Sale | $69.41 | 2,111 | $146.5K | — | |
TARS | Farrow Jeffrey S | — | Jun 17, 2025 | Proposed Sale | $40.42 | 13,608 | $550.1K | — | |
TARS | Farrow Jeffrey S | — | Mar 20, 2025 | Proposed Sale | $50.11 | 1,186 | $59.4K | — | |
TARS | Farrow Jeffrey S | — | Mar 19, 2025 | Proposed Sale | $47.40 | 1,254 | $59.4K | — | |
TARS | Farrow Jeffrey S | — | Mar 18, 2025 | Proposed Sale | $46.28 | 1,284 | $59.4K | — |